Compromiso Pulmonar en ARTRITIS REUMATOIDEA
•
19 gefällt mir•7,863 views
Compromiso Pulmonar en ARTRITIS REUMATOIDEA Presentación final rota Reumato UdeC MI
Empfohlen
Weitere ähnliche Inhalte
Was ist angesagt?
Was ist angesagt? (20)
Andere mochten auch
Andere mochten auch (20)
Ähnlich wie Compromiso Pulmonar en ARTRITIS REUMATOIDEA
Ähnlich wie Compromiso Pulmonar en ARTRITIS REUMATOIDEA (20)
Mehr von Julián Vega Adauy
Mehr von Julián Vega Adauy (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
Compromiso Pulmonar en ARTRITIS REUMATOIDEA
- 1. COMPROMISO PULMONAR EN ARTRITIS REUMATOIDEA Miércoles 23 de Junio 2010 Julián Vega Adauy , Residente Medicina Interna Universidad de Concepción PRESENTACION FINAL ROTACION REUMATOLOGIA
- 9. HIPERTENSIÓN PULMONAR 2ria EPD PRIMARIA (ASOCIADA) ETE crónica ENFERMEDAD TEJ CONECTIVO K. Fagan. Progress in Cardiovascular Diseases 2002
- 10. E. Kim. Radiographics 2002 COMPROMISO PULMONAR Y CTD
- 12. — INTRODUCCION K Brown. Proceedings ATS. 2007
- 13. — INTRODUCCION K Brown. Proceedings ATS. 2007 IMPORTANCIA DEL COMPROMISO EXT-ART Claro impacto en mortalidad
- 16. — ANTECEDENTES HISTÓRICOS DEL PULMÓN REUMATOIDEO Ellman, BMJ. 1948 Relación entre casos de AR con compromiso pulmonar difuso Caplan, thorax. 1953 Neumoconiosis asociada a AR en trabajadores del carbón Patrón nodular particular, distinto al de la llamada Fibrosis pulmonar masiva 1954, fueron reportados Nódulos pulmonares en ausencia de Neumoconiosis Sinclair. Q J Med. 1955 Alta frecuencia de compromiso pleural en AR Cudkowicz Br J Dis Chest 1961 Describió primeras biopsias y estudios de Fx pulmonar en AR + Compromiso pulmonar
- 18. Current Opin Rheumatol 2008 COMPROMISO PULMONAR AR
- 19. Current Opin Rheumatol 2008 COMPROMISO PULMONAR AR Variadas manifestaciones pleuro-pulmonares de la AR
- 25. LIQUIDO PLEURAL EN DP x AR
- 28. V Luiza. J. Pneumologia 2003
- 29. V Luiza. J. Pneumologia 2003
- 30. Source: Johns Hopkins Arthritis
- 36. COMPROMISO NODULAR PULMONAR No Neumocócicos (Necrobióticos) Neumocócicos (Sd. Caplan)
- 52. PATRONES DE EPD
- 59. Park JH. Am J Respir Crit Care Med 2007 UIP no AR UIP AR
- 64. COMPROMISO PULMONAR AR, RX + TAC Current Opin Rheumatol 2008 60-90% Opacidades reticulares 28% Panal de abejas 28% Vidrio esmerilado 25% Atrapamiento aéreo 5-10-30% Nódulos 75% Bronquiectasias FRECUENCIA HALLAZGO
- 72. D’ Alonzo GE. Ann Int Med. 1991 HAP, HISTORIA NATURAL
- 73. ACCF/AHA Expert Consensus Document on Pulmonary Hypertension. J. Am. Coll. Cardiol. 2009 HAP, SOBREVIDA SEGÚN ETIOLOGIA
- 74. ACCF/AHA Expert Consensus Document on Pulmonary Hypertension. J. Am. Coll. Cardiol. 2009 HAP, SOBREVIDA SEGÚN ETIOLOGIA HAP asociada a CTD es uno de los grupos con peor sobrevida
- 78. UpToDate 18.3. 2010 Obstrucción vía a 2 COMPROMISO VIA a2 BAJA HiperRx. Ha sido controversial Cofounders TABACO + EPD: 60% Ajustado: 20% Etiología Multifactorial RP: Like-Asma
- 80. DAÑO COLATERAL COMPROMISO PULMONAR POR TRATAMIENTO DE AR
- 84. FACTORES DE RIESGO PARA COMPROMISO PULMONAR DE MTX
- 85. G. Cannon. Rheumatic disease clinics of North America. 1997 SINDROMES PULMONARES POR MTX +F 2-5% Nódulos pulmonares Pleuritis, Derrame Pleural Edema Pulmonar Agudo No Cardiogénico EPD por MTX Neumonitis Aguda Intersticial (Rx HS)
- 89. Riesgo NEUMONITIS por MTX
- 91. V Saravanan. Rheumatology 2004
- 94. MTX + COMPROMISO PULMONAR A Sikka. JIACM. 2006
- 95. C. Rayner, S. Grubnic. Best Practice & Research Clinical Rheumatology. 2004 ARTRITIS REUMATOIDEA (AR) EVALUACION PULMONAR
- 97. Muchas gracias por su atención foto de la vida real
- 98. COMPROMISO PULMONAR EN ARTRITIS REUMATOIDEA Muchas Gracias por su atención
Hinweis der Redaktion
- Most Frequent High-resolution Computed Tomography Patterns in Rheumatoid Arthritis Associated Interstitial Lung Disease (ILD)
- Generalmente subclínica Autopsias 40-70% Pleuresía 5-20% Derrame Rx 5%
- Unique pleural fluid findings in RA. Triad of comet cells, giant cells and background of granular material. Seen in as many as 80% of pleural specimens and are considered unique to RA. These findings are the result of the exfoliation of pleural components from regions of granulomatous pleuritis. The RA cell (or ragocyte) is a leukocyte with small cytoplasmic lipid inclusions containing RF. These may also be seen in TB.
- Caplan A. Certain radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Torax 1953;8:29-37.
- Caplan A. Certain radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Torax 1953;8:29-37.
- Caplan A. Certain radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Torax 1953;8:29-37.
- Caplan A. Certain radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Torax 1953;8:29-37.
- Caplan A. Certain radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Torax 1953;8:29-37.
- Caplan A. Certain radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Torax 1953;8:29-37.
- Comparison of the Kaplan-Meier survival curves between the subject groups and the UIP pattern associated with rheumatoid arthritis (RA-UIP). CVD-NSIP = nonspecific interstitial pneumonia associated with collagen vascular diseases; I-NSIP = idiopathic nonspecific interstitial pneumonia; IPF/UIP = idiopathic pulmonary fibrosis/usual interstitial pneumonia; non–RA-UIP = usual interstitial pneumonia in the patients with non–rheumatoid arthritis–collagen vascular diseases. The statistical significances between groups were as follows: RA-UIP versus non–RA-UIP, p = 0.015; RA-UIP versus CVD-NSIP, p = 0.043; RA-UIP versus I-NSIP, not significant; RA-UIP versus IPF/UIP, not significant. Reprinted by permission from Reference Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, Colby TV. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007;175:705–711
- Grupo 1: EPD + tos seca + disnea Grupo 2: Alteraciones no EPD Grupo 3: Sin EPD
- Grupo 1: EPD + tos seca + disnea Grupo 2: Alteraciones no EPD Grupo 3: Sin EPD
- Table 2. Most Frequent Pulmonary Abnormalities Detected with High-resolution Computed Tomography Patterns in Rheumatoid Arthritis
- Grupo 1: EPD + tos seca + disnea Grupo 2: Alteraciones no EPD Grupo 3: Sin EPD
- Most Frequent High-resolution Computed Tomography Patterns in Rheumatoid Arthritis Associated Interstitial Lung Disease (ILD)
- Most Frequent High-resolution Computed Tomography Patterns in Rheumatoid Arthritis Associated Interstitial Lung Disease (ILD)
- Most Frequent High-resolution Computed Tomography Patterns in Rheumatoid Arthritis Associated Interstitial Lung Disease (ILD)
- 1. Zisman D A, McCune W J, Tino G, Lynch J P I. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 243-2522. Dai M S, Ho C L, Chen Y C, Kao W Y, Chao T Y. Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of literature. Annals of Hematology 2000; 79: 696-6993. Imokawa S, Colby T V, Leslie K O, Helmers R A. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15: 373-3814. McKenna K E, Burrows D. Pulmonary toxicity in a patient with psoriasis receiving methotrexate therapy. Clin Exp Dermatol 2000; 25: 24-275. Sing A, Leitritz L, Roggenkamp A, Kolb H J, Szabados A, Fingerle V, Autenrieth I B, Heesemann J. Pulmonary toxoplasmosis in bone marrow transplant recipients: Report of two cases and review. Clin Infect Dis 1999; 29: 429-433 6. Suwa A, Hirakata M, Satoh S, Mimori T, Utsumi K, Inada S. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: Improvement with i.v. cyclophosphamide therapy. Clin Exp Rheumatol 1999; 17: 355-3587. Yoshida S, Onuma K, Akahori K, Sakamoto H, Yamawaki Y, Shoji T, Nakagawa H, Hasegawa H, Amayasu H. Elevated levels of IL-8 in interstitial pneumonia induced by low-dose methotrexate. Journal of Allergy and Clinical Immunology 1999; 103: 952-9548. Zingg K, Grossenbacher M, Conen D, Truninger K. Methotrexat-Pneumonitis. Schweizerische Rundschau Medizinische Praxis 1999; 88: 573-5789. Aaron S D, Dales R E, Pham B. Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomized clinical trials. Respir Med 1998; 92: 1059-106510. Bartram S A. Experience with methotrexate-associated pneumonitis in northeastern England: comment on the article by Kremer et al. Arthr Rheum 1998; 41: 1327-132811. Camiciottoli G, Trapani S, Castellani W, Ginanni R, Ermini M, Falcini F. Effect on lung function of methotrexate and non-steroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis. Rheumatol Int 1998; 18: 11-1612. Cron R Q, Sherry D D, Wallace C A. Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J Pediatr 1998; 132: 901-90213. Hassanein T, Monson P, Chatfield E, DeGuzman L, El Mola T. Hign ANA levels do not preclude interferon therapy in patients with chronic hepatitis C infection. American Journal of Gastroenterology 1998; 93: 167614. Kremer J M. Experience with methotrexate-associated pneumonitis in northeastern England. Arthr Rheum 1998; 41: 1328-132815. Mateo I, Canete C, Nolla J M, Fiter J, Rodriguez Sanchon B, Romero P. Evolution of pulmonary function in rheumatoid arthritis patients taking methotrexate. Br J Rheumatol 1998; 37 (Suppl 1): 11816. Weinblatt M E, Maier A L, Fraser P A, Coblyn J S. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: conclusion after 132 months of therapy. J Rheumatol 1998; 25: 238-24217. Clearkin R, Corris P A, Thomas S H L. Methotrexate pneumonitis in a patient with rheumatoid arthritis. Postgrad Med J 1997; 73: 603-60418. Horrigan T J, Fanning J, Marcotte M P. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gynecol 1997; 176: 714-71519. Ohosone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M, Mimori T, Akizuki M, Ikeda Y. Clinical characteristics of patients with rheumatoid arthritis and methotrexate-induced pneumonitis. J Rheumatol 1997; 24: 2299-230320. Salaffi F, Manganelli P, Carotti M, Subiaco S, Lamanna G, Cervini C. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature. Clin Rheumatol 1997; 16: 296-30421. Schnabel A, Richter C, Bauerfeind S, Gross W L. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax 1997; 52: 377-37922. Thomas E, Mazyad H, Olive P, Blotman F. Cytomegalovirus-induced pneumonia in a rheumatoid arthritis patient treated with low dose methotrexate. Clin Exp Rheumatol 1997; 15: 583-58423. Alkins S A, Byrd J C, Morgan S K, Ward F T, Weiss R B. Anaphylactoid reactions to methotrexate. Cancer 1996; 77: 2123-212624. Schnabel A, Dalhoff K, Bauerfeind S, Barth J, Gross W L. Sustained cough in methotrexate therapy for rheumatoid arthritis. Clin Rheumatol 1996; 15: 277-28225. Israel C M. Severe pneumonitis as complication of low-dose methotrexate therapy in psoriasis-related polyarthritis. Reply. Dtsch Med Wschr 1995; 120: 1224-122526. van der Veen M J, Dekker J J, Dinant H J, Van Soesbergen R M, Bijlsma J W J. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis. J Rheumatol 1995; 22: 1766-176827. Carroll G J, Thomas R, Pathouros C C, Atchinson M H, Leslie A L, Cook N J, D'Souza I. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 1994; 21: 51-5428. Hollingsworth H M. Drug-related bronchiolitis-obliterans organizing pneumonia. Diseases of the bronchioles. In: Epler G R, ed. Diseases of the bronchioles. New York: Raven Press, Ltd; 1994: 367-37629. LeMense G P, Sahn S A. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med 1994; 150: 258-26030. Sharma A, Provenzale D, McKusick A, Kaplan M M. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology 1994; 107: 266-27031. Stenger A A M E. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. Scan J Rheumatol 1994; 23: 51-5332. Bohon P, Dugernier T, Debongnie J C, Pirenne B. Hypersensitivity interstitial pneumopathy and ulcero-hemorrhagic rectocolitis: Role of methotrexate. Acta Gastroenterol Belg 1993; 56: 352-35733. Buchbinder R. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol 1993; 20: 639-64434. Iki S, Yoshinaga K, Ohbayashi Y, Urabe A. Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF - Clinical attention. Ann Hematol 1993; 66: 217-21835. Kane G C, Troshinsky M B, Peters S P, Israel H L. Pneumocystis carinii pneumonia associated with weekly methotrexate: cumulative dose of methotrexate and low CD4 cell count may predict this complication. Respir Med 1993; 87: 153-15536. Leduc D, De Vuyst P, Lheureux P, Gevenois P-A, Jacobovitz D, Yernault J-C. Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Chest 1993; 104: 1620-162337. Cook N J, Carroll G J. Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis. Ann Rheum Dis 1992; 51: 272-27438. de Bandt M, Rat A C, Palazzo E, Kahn M-F. Delayed methotrexate pneumonitis. J Rheumatol 1992; 18: 194339. Hassan W, Carpenter M, Kelly C. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis. Thorax 1992; 48: 19140. Kerstens P J S M, Van Loenhout J W A, Boerbooms A M T, Van de Putte L B A. Methotrexate, pneumonitis, and infection. Ann Rheum Dis 1992; 51: 117941. Padley S P G, Adler B, Hansell D M, Müller N L. High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992; 46: 232-23642. Schoenfeld A, Mashiach R, Vardy M, Ovadia J. Methotrexate pneumonitis in nonsurgical treatment of ectopic pregnancy. Obtstet Gynecol 1992; 80: 520-52143. Vallerand H, Cossart C, Milosevic D, Lavaud F, Leone J. Fatal Pneumocystis pneumonia in asthmatic patient treated with methotrexate. Lancet 1992; 339: 155144. Weinblatt M E. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-months update. Arthr Rheum 1992; 35: 129-13745. Akoun G M, Cadranel J L, Milleron B J, Flammang D'Ortho M P, Mayaud C M. Bronchoalveolar lavage cell data in 19 patients with drug-associated pneumonitis (except amiodarone). Chest 1991; 99: 98-10446. Antonelli M S, Moreland L W, Brick J E. Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med 1991; 90: 295-?47. Kuitert L M, Harrison A C. Pneumocytis carinii pneumonia as a complication of methotrexate treatment of asthma. Thorax 1991; 46: 936-93748. Scully C J. Long-term methotrexate therapy for rheumatoid arthritis. J Rheumatol 1991; 14: 74-7949. Wollner A, Mohle-Boetani J, Lambert R E, Perruquet J L, Raffin T A, McGuire J L. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax 1991; 46: 205-20750. Carmichael A J, Ryatt K S. Pneumocystis carinii pneumonia following methotrexate. Br J Dermatol 1990; 122: 29151. Drosos A A. Methotrexate therapy in rheumatoid arthritis. Clin Rheumatol 1990; 9: 333-34152. Furst D E, Erikson N, Clute L, Koehnke R, Burmeister L F, Kohler J A. Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. 1990; 17: 1628-163553. Schwartz G F, Anderson S T. Methotrexate induced pneumonitis in a young woman with psoriasis and rheumatoid arthritis. J Rheumatol 1990; 17: 98054. Alarcon G S, Gipsen J G, Koopman W J. Severe reversible interstitial pneumonitis induced by low dose methotrexate. J Rheumatol 1989; 16: 1007-100855. Alarcon G S, Tracy I C, Blackburn W D, Jr. Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthr Rheum 1989; 32: 671-67656. Hanrahan P S, Scrivens G A, Russell A S. Prospective long-term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 1989; 28: 147-15357. McKendry R J R, Cyr M. Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients. Arch Intern Med 1989; 149: 685-68958. Shiroky J B, Watts C S, Neville C. Combination of methotrexate and sulfasalazine in the management of rheumatoid arthritis: case observations. Arthr Rheum 1989; 32: 1160-116459. White D A, Rankin J A, Stover D E, Gellene R A, Gupta S. Methotrexate pneumonitis: bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989; 139: 18-2160. Ridley M G, Wolfe C S, Mathews J A. Life-threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature. Ann Rheum Dis 1988; 47: 784-78861. van Deursen C T B M, Koudstaal J, Maesen F P V. A patient with methotrexate lung and granulomatous changes in the liver - Or just sarcoidosis ? Int J Clin Pharmacol Ther Toxicol 1988; 26: 293-29662. Bell M J, Geddie W R, Gordon D A, Reynolds W J. Pre-existing lung disease in patients with rheumatoid arthritis may predispose to methotrexate lung. Arthr Rheum 1987; 29: S7563. Carson C W, Cannon G W, Egger M J, Ward J R, Clegg D O. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthr Rheum 1987; 16: 186-19564. Gispen J G, Alarcon G S, Johnson J J, Acton R T, Barger B O, Koopman W J. Toxicity to methotrexate in rheumatoid arthritis. J Rheumatol 1987; 14: 74-7965. Philips T J, Hugh Jones D, Baker H. Pulmonary complications following methotrexate therapy. J Am Acad Dermatol 1987; 16: 373-37566. Searles G, McKendry R J R. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol 1987; 14: 1164-117167. Tugwell P, Bennett K, Gent M. Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety. Ann Intern Med 1987; 107: 358-36668. Akoun G M, Mayaud C M, Touboul J L, Denis M. Methotrexate induced pneumonitis: diagnostic value of bronchoalveolar lavage cell data. Arch Intern Med 1986; 146: 804-80569. Boh L E, Schuna A A, Pitterle M E, Adams E M, Sundstrom W R. Low-dose weekly oral methotrexate therapy for inflammatory arthritis. Clin Pharm 1986; 5: 503-50870. Brooks B J, Seifter E J, Walsh T E, Lichter A S, Bunn P A, Zabell A, Johnston-Early A, Edison M, Makuch R W, Cohen M H, Glatstein E, Ihde D. Pulmonary toxicity with combined modality therapy for limited stage small small cell lung cancer. J Clin Oncol 1986; 4: 200-20971. Kremer J M, Joong K L. The safety and efficacy of the use of methotrexate in long term therapy for rheumatoid arthritis. Arthr Rheum 1986; 29: 822-83172. Louie S, Lillington G A. Low dose methotrexate pneumonitis in rheumatois arthritis. Thorax 1986; 41: 703-70473. Maier W P, Leon-Perez R, Miller S B. Pneumonitis during low-dose methotrexate therapy. Arch Intern Med 1986; 146: 602-60374. St Clair E W, Rice J R, Snyderman R. Pneumonitis during low-dose methotrexate therapy. Arch Intern Med 1986; 146: 60375. St Clair E W, Rice J R, Snyderman R. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch Intern Med 1985; 145: 2035-203876. Akoun G M, Mayaud C M, Milleron B J, Perrot J Y. Drug-related pneumonitis and drug-induced hypersensitivity pneumonitis. Lancet 1984; i: 136277. Haim N, Kedar A, Robinson E. Methotrexate-related deaths in patients previously treated with cis-diamminedichloride platinum. Cancer Chemother Pharmacol 1984; 13: 223-22578. Nelson J A, Drake S. Potentiation of methotrexate toxicity by dipyridamole. Cancer Res 1984; 44: 2493-249679. Zeller J M, Buys C M, Gudewicz P W. Effects of high-dose methotrexate on rat alveolar and inflammatory macrophage macrophage populations. Inflammation 1984; 8: 231-23980. Zimmerman M S, Ruckdeschel J C, Hussain M. Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer. J Clin Oncol 1984; 2: 396-40581. Engelbrecht J A, Calhoon S L, Scherrer J J. Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis. Arthr Rheum 1983; 26: 1275-127882. Urban C, Nirenberg A, Caparros B, Anac S, Cacavio A, Rosen G. Chemical pleuritis as the cause of acute chest pain following high-dose methotrexate treatment. Cancer 1983; 51: 34-3783. van Hoof A, Tricot G, Verwilghen R L. Intermediate dose methotrexate and recurrent pleural effusions. Acta Clin Belg 1983; 38: 388-39084. Bernstein M L, Sobel D B, Wimmer R S. Noncardiogenic pulmonary edema following injection of methotrexate into the cerebrospinal fluid. Cancer 1982; 50: 866-86885. Bortin M M, Kay H E M, Gale R P, Rimm A A. Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukemia. Lancet 1982; i: 437-43986. Camus P, Knopf J F, Olsson N O, Reybet-Degat O, Jeannin L. Pneumopathie au methotrexate, hypocomplémentémie et immuns complexes. Rev Fr Mal Respir 1981; 9: 64-6587. Camus P, Reybet-Degat O, Michiels R, Jeannin L. Pneumopathie au methotrexate associé à des agglutinines froides. Presse Med 1981; 9: 369888. Weiss J R, Bruno S. Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med 1981; 94: 66-7289. Rohatgi P K, Halvarson L. Unilateral methotrexate-induced pneumonitis. J Natl Med Assoc 1980; 72: 896-89990. Bedrossian C W M, Miller W C, Luna M A. Methotrexate-induced diffuse interstitial pulmonary fibrosis. South Med J 1979; 72: 313-31891. Hanawa M, Fujisawa H. A case of interstitial pneumonitis induced by intrathecal injection of methotrexate. Nippon Kyobu Shikkan Gakkai Zasshi 1979; 17: 737-74192. Lewis W J, Walter J F. Methotrexate-induced pulmonary fibrosis. Arch Dermatol 1979; 115: 1169-117093. Verdich J, Christensen A L. Pulmonary disease complicating intermittent methotrexate therapy of psoriasis. Acta Derm Venerol (Stockh) 1979; 59: 471-47394. Guerra Tapia A, Moreno Izquierdo R, Barrio-Fuertes A, Merino Monge E. Fibrosis pulmonar debida a tratamiento con methotrexate. Acta Dermo-Sifiliogr 1978; 69: 301-30895. Kaplan R L, Waite D H. Progressive interstitial lung disease from prolonged methotrexate therapy. Arch Dermatol 1978; 114: 1800-180296. Lewis M J, Cameron A H, Stah K J, Purdham D R, Mann J R. Giant-cell pneumonia caused by measles and methotrexate in childhood leukemia in remission. Br Med J 1978; i: 330-33197. Sybert A, Butler T P. Sarcoidosis following adjuvant high- ose methotrexate therapy for osteosarcoma. Arch Intern Med 1978; 138: 488-48998. Lascari A D, Strano A J, Johnson W W, Collins J G P. Methotrexate-induced sudden fatal pulmonary reaction. Cancer 1977; 40: 1393-139799. Manni J J, van den Broek P. Pulmonary complications of methotrexate therapy. Clin Otolaryngol 1977; 2: 131-137100. Walden P A M, Mitchell-Heggs P F, Coppin C, Dent J, Bagshawe K D. Pleurisy and methotrexate treatment. Br Med J 1977; ii: 967101. Gutin P H, Green M R, Bleyer W A, Bauer V L, Wiernik P H, Walker M D. Methotrexate pneumonitis induced by intrathecal methotrexate therapy. A case report with parmacokinetic data. Cancer 1976; 38: 1529-1534102. Nesbit M, Krivit W, Heyn R, Sharp H. Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems. Cancer 1976; 37: 1048-1054103. Sostman H D, Matthay R A, Putman C E, Walker Smith G J. Methotrexate-induced pneumonitis. Medicine (Baltimore) 1976; 55: 371-388104. From E. Methotrexate pneumonitis in a psoriatic. Br J Dermatol 1975; 93: 107-110105. Bhat K S S, Anderson K R, Stewart R D H. Lung disease associated with methotrexate therapy. Aust NZ J Med 1974; 4: 277-280106. Bellini F, Masera G. Pulmonary disease complicating therapy with methotrexate. Ann Radiol 1973; 16: 267-271107. Everts C S, Wescott J L, Bragg D G. Methotrexate therapy and pulmonary disease. Radiology 1973; 107: 539-543108. Lisbona A, Schwartz J, Lachance C, Frank H, Palayew M J. Methotrexate-induced pulmonary disease. J Can Assoc Radiol 1973; 24: 215-220109. Robbins K M, Gribetz I, Strauss L, Leonidas J C, Sanders M. Pneumonitis in acute lymphatic leukemia during methotrexate therapy. J Pediatr 1973; 82: 84-88110. Whitcomb M E, Schwartz M I, Tormey D C. Methotrexate pneumonitis: case report and review of the literature. Thorax 1972; 27: 636-639111. Dietzsch H-J, Lorenz K, Roschlau G. Lungenveränderungen bei Methotrexate-Behandlung im Kindesalter. Dtsch Gesundh Wochenschr 1971; 26: 174-178112. Filip D J, Logue G L, Harle T S, Farrar W H. Pulmonary and hepatic complications of methotrexate therapy for psoriasis. JAMA 1971; 216: 881-882113. Pasquinucci G, Ferrara P, Castellari R. Daunorubicin treatment of methotrexate pneumonia. JAMA 1971; 216: 2017114. Rawbone R G, Shaw M T, Jackson J G, Bagshawe K D. Complication of methotrexate-maintained remission in lymphoblastic leukaemia. Br Med J 1971; 4: 467-468115. Robertson J H. Pneumonia and methotrexate. Br Med J 1970; 2: 156116. Clarysse A M, Cathey W J, Cartwright G E, Wintrobe M M. Pulmonary disease complicating intermittent therapy with methotrexate. JAMA 1969; 209: 1861-1864117. Schwartz I R, Kajani M K. Methotrexate therapy and pulmonary disease. JAMA 1969; 210: 1924
- 1. Zisman D A, McCune W J, Tino G, Lynch J P I. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 243-2522. Dai M S, Ho C L, Chen Y C, Kao W Y, Chao T Y. Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of literature. Annals of Hematology 2000; 79: 696-6993. Imokawa S, Colby T V, Leslie K O, Helmers R A. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15: 373-3814. McKenna K E, Burrows D. Pulmonary toxicity in a patient with psoriasis receiving methotrexate therapy. Clin Exp Dermatol 2000; 25: 24-275. Sing A, Leitritz L, Roggenkamp A, Kolb H J, Szabados A, Fingerle V, Autenrieth I B, Heesemann J. Pulmonary toxoplasmosis in bone marrow transplant recipients: Report of two cases and review. Clin Infect Dis 1999; 29: 429-433 6. Suwa A, Hirakata M, Satoh S, Mimori T, Utsumi K, Inada S. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: Improvement with i.v. cyclophosphamide therapy. Clin Exp Rheumatol 1999; 17: 355-3587. Yoshida S, Onuma K, Akahori K, Sakamoto H, Yamawaki Y, Shoji T, Nakagawa H, Hasegawa H, Amayasu H. Elevated levels of IL-8 in interstitial pneumonia induced by low-dose methotrexate. Journal of Allergy and Clinical Immunology 1999; 103: 952-9548. Zingg K, Grossenbacher M, Conen D, Truninger K. Methotrexat-Pneumonitis. Schweizerische Rundschau Medizinische Praxis 1999; 88: 573-5789. Aaron S D, Dales R E, Pham B. Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomized clinical trials. Respir Med 1998; 92: 1059-106510. Bartram S A. Experience with methotrexate-associated pneumonitis in northeastern England: comment on the article by Kremer et al. Arthr Rheum 1998; 41: 1327-132811. Camiciottoli G, Trapani S, Castellani W, Ginanni R, Ermini M, Falcini F. Effect on lung function of methotrexate and non-steroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis. Rheumatol Int 1998; 18: 11-1612. Cron R Q, Sherry D D, Wallace C A. Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J Pediatr 1998; 132: 901-90213. Hassanein T, Monson P, Chatfield E, DeGuzman L, El Mola T. Hign ANA levels do not preclude interferon therapy in patients with chronic hepatitis C infection. American Journal of Gastroenterology 1998; 93: 167614. Kremer J M. Experience with methotrexate-associated pneumonitis in northeastern England. Arthr Rheum 1998; 41: 1328-132815. Mateo I, Canete C, Nolla J M, Fiter J, Rodriguez Sanchon B, Romero P. Evolution of pulmonary function in rheumatoid arthritis patients taking methotrexate. Br J Rheumatol 1998; 37 (Suppl 1): 11816. Weinblatt M E, Maier A L, Fraser P A, Coblyn J S. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: conclusion after 132 months of therapy. J Rheumatol 1998; 25: 238-24217. Clearkin R, Corris P A, Thomas S H L. Methotrexate pneumonitis in a patient with rheumatoid arthritis. Postgrad Med J 1997; 73: 603-60418. Horrigan T J, Fanning J, Marcotte M P. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gynecol 1997; 176: 714-71519. Ohosone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M, Mimori T, Akizuki M, Ikeda Y. Clinical characteristics of patients with rheumatoid arthritis and methotrexate-induced pneumonitis. J Rheumatol 1997; 24: 2299-230320. Salaffi F, Manganelli P, Carotti M, Subiaco S, Lamanna G, Cervini C. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature. Clin Rheumatol 1997; 16: 296-30421. Schnabel A, Richter C, Bauerfeind S, Gross W L. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax 1997; 52: 377-37922. Thomas E, Mazyad H, Olive P, Blotman F. Cytomegalovirus-induced pneumonia in a rheumatoid arthritis patient treated with low dose methotrexate. Clin Exp Rheumatol 1997; 15: 583-58423. Alkins S A, Byrd J C, Morgan S K, Ward F T, Weiss R B. Anaphylactoid reactions to methotrexate. Cancer 1996; 77: 2123-212624. Schnabel A, Dalhoff K, Bauerfeind S, Barth J, Gross W L. Sustained cough in methotrexate therapy for rheumatoid arthritis. Clin Rheumatol 1996; 15: 277-28225. Israel C M. Severe pneumonitis as complication of low-dose methotrexate therapy in psoriasis-related polyarthritis. Reply. Dtsch Med Wschr 1995; 120: 1224-122526. van der Veen M J, Dekker J J, Dinant H J, Van Soesbergen R M, Bijlsma J W J. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis. J Rheumatol 1995; 22: 1766-176827. Carroll G J, Thomas R, Pathouros C C, Atchinson M H, Leslie A L, Cook N J, D'Souza I. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 1994; 21: 51-5428. Hollingsworth H M. Drug-related bronchiolitis-obliterans organizing pneumonia. Diseases of the bronchioles. In: Epler G R, ed. Diseases of the bronchioles. New York: Raven Press, Ltd; 1994: 367-37629. LeMense G P, Sahn S A. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med 1994; 150: 258-26030. Sharma A, Provenzale D, McKusick A, Kaplan M M. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology 1994; 107: 266-27031. Stenger A A M E. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. Scan J Rheumatol 1994; 23: 51-5332. Bohon P, Dugernier T, Debongnie J C, Pirenne B. Hypersensitivity interstitial pneumopathy and ulcero-hemorrhagic rectocolitis: Role of methotrexate. Acta Gastroenterol Belg 1993; 56: 352-35733. Buchbinder R. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol 1993; 20: 639-64434. Iki S, Yoshinaga K, Ohbayashi Y, Urabe A. Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF - Clinical attention. Ann Hematol 1993; 66: 217-21835. Kane G C, Troshinsky M B, Peters S P, Israel H L. Pneumocystis carinii pneumonia associated with weekly methotrexate: cumulative dose of methotrexate and low CD4 cell count may predict this complication. Respir Med 1993; 87: 153-15536. Leduc D, De Vuyst P, Lheureux P, Gevenois P-A, Jacobovitz D, Yernault J-C. Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Chest 1993; 104: 1620-162337. Cook N J, Carroll G J. Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis. Ann Rheum Dis 1992; 51: 272-27438. de Bandt M, Rat A C, Palazzo E, Kahn M-F. Delayed methotrexate pneumonitis. J Rheumatol 1992; 18: 194339. Hassan W, Carpenter M, Kelly C. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis. Thorax 1992; 48: 19140. Kerstens P J S M, Van Loenhout J W A, Boerbooms A M T, Van de Putte L B A. Methotrexate, pneumonitis, and infection. Ann Rheum Dis 1992; 51: 117941. Padley S P G, Adler B, Hansell D M, Müller N L. High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992; 46: 232-23642. Schoenfeld A, Mashiach R, Vardy M, Ovadia J. Methotrexate pneumonitis in nonsurgical treatment of ectopic pregnancy. Obtstet Gynecol 1992; 80: 520-52143. Vallerand H, Cossart C, Milosevic D, Lavaud F, Leone J. Fatal Pneumocystis pneumonia in asthmatic patient treated with methotrexate. Lancet 1992; 339: 155144. Weinblatt M E. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-months update. Arthr Rheum 1992; 35: 129-13745. Akoun G M, Cadranel J L, Milleron B J, Flammang D'Ortho M P, Mayaud C M. Bronchoalveolar lavage cell data in 19 patients with drug-associated pneumonitis (except amiodarone). Chest 1991; 99: 98-10446. Antonelli M S, Moreland L W, Brick J E. Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med 1991; 90: 295-?47. Kuitert L M, Harrison A C. Pneumocytis carinii pneumonia as a complication of methotrexate treatment of asthma. Thorax 1991; 46: 936-93748. Scully C J. Long-term methotrexate therapy for rheumatoid arthritis. J Rheumatol 1991; 14: 74-7949. Wollner A, Mohle-Boetani J, Lambert R E, Perruquet J L, Raffin T A, McGuire J L. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax 1991; 46: 205-20750. Carmichael A J, Ryatt K S. Pneumocystis carinii pneumonia following methotrexate. Br J Dermatol 1990; 122: 29151. Drosos A A. Methotrexate therapy in rheumatoid arthritis. Clin Rheumatol 1990; 9: 333-34152. Furst D E, Erikson N, Clute L, Koehnke R, Burmeister L F, Kohler J A. Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. 1990; 17: 1628-163553. Schwartz G F, Anderson S T. Methotrexate induced pneumonitis in a young woman with psoriasis and rheumatoid arthritis. J Rheumatol 1990; 17: 98054. Alarcon G S, Gipsen J G, Koopman W J. Severe reversible interstitial pneumonitis induced by low dose methotrexate. J Rheumatol 1989; 16: 1007-100855. Alarcon G S, Tracy I C, Blackburn W D, Jr. Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthr Rheum 1989; 32: 671-67656. Hanrahan P S, Scrivens G A, Russell A S. Prospective long-term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 1989; 28: 147-15357. McKendry R J R, Cyr M. Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients. Arch Intern Med 1989; 149: 685-68958. Shiroky J B, Watts C S, Neville C. Combination of methotrexate and sulfasalazine in the management of rheumatoid arthritis: case observations. Arthr Rheum 1989; 32: 1160-116459. White D A, Rankin J A, Stover D E, Gellene R A, Gupta S. Methotrexate pneumonitis: bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989; 139: 18-2160. Ridley M G, Wolfe C S, Mathews J A. Life-threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature. Ann Rheum Dis 1988; 47: 784-78861. van Deursen C T B M, Koudstaal J, Maesen F P V. A patient with methotrexate lung and granulomatous changes in the liver - Or just sarcoidosis ? Int J Clin Pharmacol Ther Toxicol 1988; 26: 293-29662. Bell M J, Geddie W R, Gordon D A, Reynolds W J. Pre-existing lung disease in patients with rheumatoid arthritis may predispose to methotrexate lung. Arthr Rheum 1987; 29: S7563. Carson C W, Cannon G W, Egger M J, Ward J R, Clegg D O. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthr Rheum 1987; 16: 186-19564. Gispen J G, Alarcon G S, Johnson J J, Acton R T, Barger B O, Koopman W J. Toxicity to methotrexate in rheumatoid arthritis. J Rheumatol 1987; 14: 74-7965. Philips T J, Hugh Jones D, Baker H. Pulmonary complications following methotrexate therapy. J Am Acad Dermatol 1987; 16: 373-37566. Searles G, McKendry R J R. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol 1987; 14: 1164-117167. Tugwell P, Bennett K, Gent M. Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety. Ann Intern Med 1987; 107: 358-36668. Akoun G M, Mayaud C M, Touboul J L, Denis M. Methotrexate induced pneumonitis: diagnostic value of bronchoalveolar lavage cell data. Arch Intern Med 1986; 146: 804-80569. Boh L E, Schuna A A, Pitterle M E, Adams E M, Sundstrom W R. Low-dose weekly oral methotrexate therapy for inflammatory arthritis. Clin Pharm 1986; 5: 503-50870. Brooks B J, Seifter E J, Walsh T E, Lichter A S, Bunn P A, Zabell A, Johnston-Early A, Edison M, Makuch R W, Cohen M H, Glatstein E, Ihde D. Pulmonary toxicity with combined modality therapy for limited stage small small cell lung cancer. J Clin Oncol 1986; 4: 200-20971. Kremer J M, Joong K L. The safety and efficacy of the use of methotrexate in long term therapy for rheumatoid arthritis. Arthr Rheum 1986; 29: 822-83172. Louie S, Lillington G A. Low dose methotrexate pneumonitis in rheumatois arthritis. Thorax 1986; 41: 703-70473. Maier W P, Leon-Perez R, Miller S B. Pneumonitis during low-dose methotrexate therapy. Arch Intern Med 1986; 146: 602-60374. St Clair E W, Rice J R, Snyderman R. Pneumonitis during low-dose methotrexate therapy. Arch Intern Med 1986; 146: 60375. St Clair E W, Rice J R, Snyderman R. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch Intern Med 1985; 145: 2035-203876. Akoun G M, Mayaud C M, Milleron B J, Perrot J Y. Drug-related pneumonitis and drug-induced hypersensitivity pneumonitis. Lancet 1984; i: 136277. Haim N, Kedar A, Robinson E. Methotrexate-related deaths in patients previously treated with cis-diamminedichloride platinum. Cancer Chemother Pharmacol 1984; 13: 223-22578. Nelson J A, Drake S. Potentiation of methotrexate toxicity by dipyridamole. Cancer Res 1984; 44: 2493-249679. Zeller J M, Buys C M, Gudewicz P W. Effects of high-dose methotrexate on rat alveolar and inflammatory macrophage macrophage populations. Inflammation 1984; 8: 231-23980. Zimmerman M S, Ruckdeschel J C, Hussain M. Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer. J Clin Oncol 1984; 2: 396-40581. Engelbrecht J A, Calhoon S L, Scherrer J J. Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis. Arthr Rheum 1983; 26: 1275-127882. Urban C, Nirenberg A, Caparros B, Anac S, Cacavio A, Rosen G. Chemical pleuritis as the cause of acute chest pain following high-dose methotrexate treatment. Cancer 1983; 51: 34-3783. van Hoof A, Tricot G, Verwilghen R L. Intermediate dose methotrexate and recurrent pleural effusions. Acta Clin Belg 1983; 38: 388-39084. Bernstein M L, Sobel D B, Wimmer R S. Noncardiogenic pulmonary edema following injection of methotrexate into the cerebrospinal fluid. Cancer 1982; 50: 866-86885. Bortin M M, Kay H E M, Gale R P, Rimm A A. Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukemia. Lancet 1982; i: 437-43986. Camus P, Knopf J F, Olsson N O, Reybet-Degat O, Jeannin L. Pneumopathie au methotrexate, hypocomplémentémie et immuns complexes. Rev Fr Mal Respir 1981; 9: 64-6587. Camus P, Reybet-Degat O, Michiels R, Jeannin L. Pneumopathie au methotrexate associé à des agglutinines froides. Presse Med 1981; 9: 369888. Weiss J R, Bruno S. Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med 1981; 94: 66-7289. Rohatgi P K, Halvarson L. Unilateral methotrexate-induced pneumonitis. J Natl Med Assoc 1980; 72: 896-89990. Bedrossian C W M, Miller W C, Luna M A. Methotrexate-induced diffuse interstitial pulmonary fibrosis. South Med J 1979; 72: 313-31891. Hanawa M, Fujisawa H. A case of interstitial pneumonitis induced by intrathecal injection of methotrexate. Nippon Kyobu Shikkan Gakkai Zasshi 1979; 17: 737-74192. Lewis W J, Walter J F. Methotrexate-induced pulmonary fibrosis. Arch Dermatol 1979; 115: 1169-117093. Verdich J, Christensen A L. Pulmonary disease complicating intermittent methotrexate therapy of psoriasis. Acta Derm Venerol (Stockh) 1979; 59: 471-47394. Guerra Tapia A, Moreno Izquierdo R, Barrio-Fuertes A, Merino Monge E. Fibrosis pulmonar debida a tratamiento con methotrexate. Acta Dermo-Sifiliogr 1978; 69: 301-30895. Kaplan R L, Waite D H. Progressive interstitial lung disease from prolonged methotrexate therapy. Arch Dermatol 1978; 114: 1800-180296. Lewis M J, Cameron A H, Stah K J, Purdham D R, Mann J R. Giant-cell pneumonia caused by measles and methotrexate in childhood leukemia in remission. Br Med J 1978; i: 330-33197. Sybert A, Butler T P. Sarcoidosis following adjuvant high- ose methotrexate therapy for osteosarcoma. Arch Intern Med 1978; 138: 488-48998. Lascari A D, Strano A J, Johnson W W, Collins J G P. Methotrexate-induced sudden fatal pulmonary reaction. Cancer 1977; 40: 1393-139799. Manni J J, van den Broek P. Pulmonary complications of methotrexate therapy. Clin Otolaryngol 1977; 2: 131-137100. Walden P A M, Mitchell-Heggs P F, Coppin C, Dent J, Bagshawe K D. Pleurisy and methotrexate treatment. Br Med J 1977; ii: 967101. Gutin P H, Green M R, Bleyer W A, Bauer V L, Wiernik P H, Walker M D. Methotrexate pneumonitis induced by intrathecal methotrexate therapy. A case report with parmacokinetic data. Cancer 1976; 38: 1529-1534102. Nesbit M, Krivit W, Heyn R, Sharp H. Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems. Cancer 1976; 37: 1048-1054103. Sostman H D, Matthay R A, Putman C E, Walker Smith G J. Methotrexate-induced pneumonitis. Medicine (Baltimore) 1976; 55: 371-388104. From E. Methotrexate pneumonitis in a psoriatic. Br J Dermatol 1975; 93: 107-110105. Bhat K S S, Anderson K R, Stewart R D H. Lung disease associated with methotrexate therapy. Aust NZ J Med 1974; 4: 277-280106. Bellini F, Masera G. Pulmonary disease complicating therapy with methotrexate. Ann Radiol 1973; 16: 267-271107. Everts C S, Wescott J L, Bragg D G. Methotrexate therapy and pulmonary disease. Radiology 1973; 107: 539-543108. Lisbona A, Schwartz J, Lachance C, Frank H, Palayew M J. Methotrexate-induced pulmonary disease. J Can Assoc Radiol 1973; 24: 215-220109. Robbins K M, Gribetz I, Strauss L, Leonidas J C, Sanders M. Pneumonitis in acute lymphatic leukemia during methotrexate therapy. J Pediatr 1973; 82: 84-88110. Whitcomb M E, Schwartz M I, Tormey D C. Methotrexate pneumonitis: case report and review of the literature. Thorax 1972; 27: 636-639111. Dietzsch H-J, Lorenz K, Roschlau G. Lungenveränderungen bei Methotrexate-Behandlung im Kindesalter. Dtsch Gesundh Wochenschr 1971; 26: 174-178112. Filip D J, Logue G L, Harle T S, Farrar W H. Pulmonary and hepatic complications of methotrexate therapy for psoriasis. JAMA 1971; 216: 881-882113. Pasquinucci G, Ferrara P, Castellari R. Daunorubicin treatment of methotrexate pneumonia. JAMA 1971; 216: 2017114. Rawbone R G, Shaw M T, Jackson J G, Bagshawe K D. Complication of methotrexate-maintained remission in lymphoblastic leukaemia. Br Med J 1971; 4: 467-468115. Robertson J H. Pneumonia and methotrexate. Br Med J 1970; 2: 156116. Clarysse A M, Cathey W J, Cartwright G E, Wintrobe M M. Pulmonary disease complicating intermittent therapy with methotrexate. JAMA 1969; 209: 1861-1864117. Schwartz I R, Kajani M K. Methotrexate therapy and pulmonary disease. JAMA 1969; 210: 1924